Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ENANTA PHARMACEUTICALS INC Director's Dealing 2021

Jan 27, 2021

33238_dirs_2021-01-27_42114603-066f-401d-ac89-939fbd860dc6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-01-25

Reporting Person: Luu Brendan (Sr. VP, Business Dev.)

More from ENANTA PHARMACEUTICALS INC

Regulatory Filings 2026
May 13
Interim / Quarterly Report 2026
May 13
Major Shareholding Notification 2026
Mar 26
Regulatory Filings 2026
Mar 26
Regulatory Filings 2026
Feb 23
Director's Dealing 2026
Feb 13
Director's Dealing 2026
Feb 13
Director's Dealing 2026
Feb 13
Director's Dealing 2026
Feb 13
Major Shareholding Notification 2026
Feb 13
View all filings →